Bost K L, Clarke B L, Xu J C, Kiyono H, McGhee J R, Pascual D
Department of Microbiology, Tulane University School of Medicine, New Orleans, LA 70112.
J Immunol. 1990 Dec 15;145(12):4326-31.
The murine B cell line CH12.LX.C4.5F5 (CH12 (5F5) expresses adrenocorticotropin (ACTH) receptors, which can modulate IgM secretion by these cells. Interestingly, the response to ACTH was concentration dependent, inducing IgM secretion at subnanomolar amounts and suppressing secretion at micromolar amounts. With the use of an enzyme-linking immunospot assay it was possible to demonstrate that the ACTH-induced increase in IgM secretion by CH12 (5F5) cells was caused at least in part by an increase in the number of cells secreting IgM. CH12 (5F5) cells activated with suboptimal concentrations of LPS demonstrated a similar biphasic response. ACTH at concentrations of 10(-13) to 10(-9) M augmented IgM secretion in LPS-activated cells as much as sixfold, whereas 10(-6) M ACTH slightly decreased LPS-induced IgM secretion. At the mRNA level, subnanomolar concentrations of ACTH increased microH chain mRNA expression up to twofold in unstimulated or LPS-stimulated CH12 (5F5) cells. Taken together, these studies show that physiologically relevant concentrations of ACTH can interact directly with receptors on these B lymphocytes to enhance IgM secretion and microH chain mRNA expression. Although ACTH does increase intracellular cAMP levels in CH12 (5F5) B cells, it is unlikely that the induction of this second messenger pathway is by itself responsible for the ACTH induced B cell differentiation. The concentration of ACTH necessary to stimulate significant intracellular cAMP increases was 10- to 100-fold higher than that required to increase IgM secretion. Furthermore, CH12 (5F5) cells treated with varying concentrations of 8-bromo cAMP or cholera toxin were inhibited in their ability to secrete IgM. These results strongly suggest that the enhancing effects of ACTH on CH12 (5F5) IgM secretion are via mechanisms independent of those mediated by cAMP.
小鼠B细胞系CH12.LX.C4.5F5(CH12 (5F5))表达促肾上腺皮质激素(ACTH)受体,该受体可调节这些细胞的IgM分泌。有趣的是,对ACTH的反应呈浓度依赖性,在亚纳摩尔量时诱导IgM分泌,而在微摩尔量时抑制分泌。使用酶联免疫斑点测定法可以证明,ACTH诱导CH12 (5F5)细胞IgM分泌增加至少部分是由于分泌IgM的细胞数量增加所致。用次优浓度的脂多糖(LPS)激活的CH12 (5F5)细胞表现出类似的双相反应。浓度为10(-13)至10(-9) M的ACTH可使LPS激活细胞中的IgM分泌增加多达六倍,而10(-6) M的ACTH则略微降低LPS诱导的IgM分泌。在mRNA水平上,亚纳摩尔浓度的ACTH可使未刺激或LPS刺激的CH12 (5F5)细胞中的μ重链mRNA表达增加两倍。综上所述,这些研究表明,生理相关浓度的ACTH可直接与这些B淋巴细胞上的受体相互作用,以增强IgM分泌和μ重链mRNA表达。尽管ACTH确实会增加CH12 (5F5) B细胞中的细胞内cAMP水平,但这种第二信使途径的诱导本身不太可能是ACTH诱导B细胞分化的原因。刺激细胞内cAMP显著增加所需的ACTH浓度比增加IgM分泌所需的浓度高10至100倍。此外,用不同浓度的8-溴cAMP或霍乱毒素处理的CH12 (5F5)细胞分泌IgM的能力受到抑制。这些结果强烈表明,ACTH对CH12 (5F5) IgM分泌的增强作用是通过独立于cAMP介导的机制实现的。